Figure 1.
Global chemogenetic manipulation of vlPAG activity suggests parallel bidirectional modulation of nociceptive behaviors. A, Constructs used in viral targeting of AAV8 hM3Dq–mCherry, AAV8 hM4Di–mCherry and AAV8–EGFP via bilateral injections into the vlPAG. B, C, Representative images of coronal sections containing vlPAG demonstrating restricted viral expression following microinjection of the AAV8 hM3Dq (B) and hM4Di (C) into the vlPAG. D, G, Relative to pretreatment baseline values, CNO (1 mg/kg, i.p.) did not have any significant effects on PWLs in mice expressing the control EGFP construct. E, H, CNO (1 mg/kg, i.p.) administration in hM3Dq-injected mice resulted in a significant increase in PWLs but not in PWTs. F, I, CNO (1 mg/kg, i.p.) administration in hM4Di-injected mice resulted in a significant decrease in PWLs and PWTs. ∗p < 0.05, ∗∗p < 0.005, ∗∗∗p < 0.0001. Scale bars, 300 and 35 μm, 4× and 10×, respectively.